279 related articles for article (PubMed ID: 18458148)
41. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations.
Nishiyama A; Yagi M; Awano H; Okizuka Y; Maeda T; Yoshida S; Takeshima Y; Matsuo M
Pediatr Int; 2009 Dec; 51(6):775-9. PubMed ID: 19438831
[TBL] [Abstract][Full Text] [Related]
42. Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans.
Bai X; Smith HE; Golden A
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38454882
[TBL] [Abstract][Full Text] [Related]
43. Seipin, adipogenesis and lipid droplets.
Fei W; Du X; Yang H
Trends Endocrinol Metab; 2011 Jun; 22(6):204-10. PubMed ID: 21497513
[TBL] [Abstract][Full Text] [Related]
44. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
[TBL] [Abstract][Full Text] [Related]
45. Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis.
Fei W; Li H; Shui G; Kapterian TS; Bielby C; Du X; Brown AJ; Li P; Wenk MR; Liu P; Yang H
J Lipid Res; 2011 Dec; 52(12):2136-2147. PubMed ID: 21957196
[TBL] [Abstract][Full Text] [Related]
46. miR-431 inhibits adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting insulin receptor substance 2.
Wang Y; Yang L; Liu X; Hong T; Wang T; Dong A; Li J; Xu X; Cao L
Stem Cell Res Ther; 2018 Aug; 9(1):231. PubMed ID: 30165902
[TBL] [Abstract][Full Text] [Related]
47. Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages.
Lee JS; Suh JM; Park HG; Bak EJ; Yoo YJ; Cha JH
Differentiation; 2008 May; 76(5):478-87. PubMed ID: 18093224
[TBL] [Abstract][Full Text] [Related]
48. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
[TBL] [Abstract][Full Text] [Related]
49. Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus.
Yang W; Thein S; Guo X; Xu F; Venkatesh B; Sugii S; Radda GK; Han W
Biochem J; 2013 May; 452(1):37-44. PubMed ID: 23458123
[TBL] [Abstract][Full Text] [Related]
50. Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions.
Davis MR; Arner E; Duffy CR; De Sousa PA; Dahlman I; Arner P; Summers KM
Mol Genet Metab; 2016 Sep; 119(1-2):174-85. PubMed ID: 27386756
[TBL] [Abstract][Full Text] [Related]
51. Adipocyte-specific deletion of zinc finger protein 407 results in lipodystrophy and insulin resistance in mice.
Charrier A; Xu X; Guan BJ; Ngo J; Wynshaw-Boris A; Hatzoglou M; Buchner DA
Mol Cell Endocrinol; 2021 Feb; 521():111109. PubMed ID: 33285243
[TBL] [Abstract][Full Text] [Related]
52. The human lipodystrophy protein seipin is an ER membrane adaptor for the adipogenic PA phosphatase lipin 1.
Sim MF; Dennis RJ; Aubry EM; Ramanathan N; Sembongi H; Saudek V; Ito D; O'Rahilly S; Siniossoglou S; Rochford JJ
Mol Metab; 2012; 2(1):38-46. PubMed ID: 24024128
[TBL] [Abstract][Full Text] [Related]
53. Seipin deficiency leads to defective parturition in mice.
Zowalaty AEE; Ye X
Biol Reprod; 2017 Sep; 97(3):378-386. PubMed ID: 29088395
[TBL] [Abstract][Full Text] [Related]
54. Ablation of
Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848133
[TBL] [Abstract][Full Text] [Related]
55. A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation.
Gale SE; Frolov A; Han X; Bickel PE; Cao L; Bowcock A; Schaffer JE; Ory DS
J Biol Chem; 2006 Apr; 281(16):11082-9. PubMed ID: 16495223
[TBL] [Abstract][Full Text] [Related]
56. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
[TBL] [Abstract][Full Text] [Related]
57. Biphasic expression of lipin suggests dual roles in adipocyte development.
Phan J; Peterfy M; Reue K
Drug News Perspect; 2005; 18(1):5-11. PubMed ID: 15753971
[TBL] [Abstract][Full Text] [Related]
58. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B
J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881
[TBL] [Abstract][Full Text] [Related]
59. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
[TBL] [Abstract][Full Text] [Related]
60. GPAT3 deficiency alleviates insulin resistance and hepatic steatosis in a mouse model of severe congenital generalized lipodystrophy.
Gao M; Liu L; Wang X; Mak HY; Liu G; Yang H
Hum Mol Genet; 2020 Feb; 29(3):432-443. PubMed ID: 31873720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]